EZH2 and cancer: Given that STAT3 is an important oncogenic transcription factor, and EZH2 is found to be mutated in many cancers, the interplay between these two proteins raises the possibility that targeting the STAT3-EZH2 axis might be beneficial to arrest or kill cancer cells.